Trial
NCT05233410
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Incyte Corporation
Collaborators
—
Condition
Chronic Hand Eczema (CHE)
Intervention
Ruxolitinib cream
Why stopped
Business decision; no safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-10